LifeSci Advisors markets its clients to the top life sciences-focused institutional investors across the U.S., Europe, and Israel. Our team has an average of over 20 years of life sciences sales experience, and we have more than 2,500 active institutional investor relationships. Importantly, our constant dialogue with virtually all lead or anchor life science-oriented funds means we have significant intelligence regarding what investment theses those institutions are interested in. Moreover, we know who to go to at these firms, what messaging will best resonate, and our long-standing and close relationships ensure timely and meaningful feedback.
In addition to deep relationships with the buy-side, LifeSci Advisors has strong connections with sell-side analysts, investment bankers, specialty salespeople, and capital markets professionals. The firm leverages these relationships on behalf of its clients to attract additional sell-side coverage, encourage investor conference invites, and to expand investment banking relationships.
LifeSci Advisors also has an extensive network of retail brokers across the U.S. interested in healthcare investment opportunities. These individuals often manage more capital than institutions.
LifeSci Advisors works with clients to develop an impactful investor communications program that start with investment thesis development and corporate positioning. Our senior laden specialized healthcare corporate communications group effectively delivers key messages to all Wall Street constituencies, including institutional investors, analysts, and bankers. We develop a concise, impactful, and compelling investment thesis that resonates globally and drive the creation of all key investor-facing collateral materials, including corporate presentations, press releases, conference call scripts, corporate fact sheets, IR websites, shareholder letters, and Q&A documents.
LifeSci Advisors hosts Key Opinion Leader (KOL) events on behalf of clients with leading life sciences industry experts that are intended to further cultivate relationships with top-tier healthcare investors and analysts. These events are focused on relevant and timely corporate, including new clinical data and important regulatory milestones.
Our KOL events can utilize LifeSci’s interactive virtual platform or be conducted in-person. These client-specific events designed to lend critical third-party validation to a company’s products or technology, and highlight them in the context of the broader healthcare landscape. LifeSci’s KOL events are excellent opportunities for clients to raise their visibility with investors/analysts and key industry stakeholders.
Capital Markets Advisory
Our team leverages deep industry relationships to prepare and guide companies on how/when to access capital markets. We provide strategic counsel on every aspect of navigating the capital markets and the approach to investor interface. LifeSci Advisors has decades of capital markets expertise based on the Wall Street backgrounds and senior-level experience in equity capital markets, sell-side research, investment banking, and as fund managers.